课题基金 / 基金详情

Using artificial pancreas closed-loop systems for the treatment of type 1 diabetes

Using artificial pancreas closed-loop systems for the treatment of type 1 diabetes
使用人工胰腺闭环系统治疗1型糖尿病
批准号：
333897
负责人：
Rabasa-Lhoret Rmi
金额：
$77.08万
依托单位：
Institut de recherches cliniques de Montral
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2015
资助国家：
加拿大
项目状态：
已结题
起止时间：
2015-09-01 至 2022-09-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=333897&lang=en
关键词：
Artificial Pancreas Closed-Loop System Glucagon Glucose Control Hypoglycemia Insulin Type 1 Diabetes

项目摘要

项目成果

Rabasa-Lhoret Rmi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
In healthy individuals, blood sugar levels are tightly controlled by 2 hormones: insulin and glucagon. Secretion of insulin, a vital hormone to reduce blood sugar, is lost in type 1 diabetes (T1D). Thus, patients with T1D are treated by insulin therapy us
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Reducing the burden of hypoglycemia for persons living with type 1 diabetes
BEhaviors, Therapies, TEchnologies and hypoglycemic Risk in Type 1 diabetes: The BETTER study
Optimizing insulin basal rate adjustments to prevent exercise-induced hypoglycemia in patients with type 1 diabetes using insulin pump therapy
Automated closed-loop control of glucose levels in type 1 diabetes patients with hypoglycemia unawareness
海外基金